Reuters logo
BRIEF-Astra CEO says Nov. 18 investor day to focus on progress, no comment on Pfizer
July 31, 2014 / 9:32 AM / 3 years ago

BRIEF-Astra CEO says Nov. 18 investor day to focus on progress, no comment on Pfizer

July 31 (Reuters) - AstraZeneca PLC CEO Pascal Soriot told reporters: * CEO says can’t comment on Pfizer, says November 18 investor day will focus on

company’s progress * CEO says hopes for outcome to DOJ probe into Plato study on Brilinta very

soon * CEO says Almirall respiratory drugs complement Pearl portfolio very well * CEO says in discussions over partnering neuroscience and anti-infective

drugs, hopes to enter collaborations in H2 * CEO says Russia events may impact company but retail focus should limit

damage * CEO says strongly committed to progressive dividend policy * For more news, please click here

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below